Gene · 8205
Papers2,064
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,064
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Altered expression of AXL receptor tyrosine kinase in gastrointestinal cancers: a promising therapeutic target. | Front Oncol | 2023 | 37469409 | PubTator, text mining | PubMed |
Sintilimab plus bevacizumab and CapeOx (BBCAPX) on first-line treatment in patients with RAS mutant, microsatellite stable, metastatic colorectal cancer: study protocol of a randomized, open-label, multicentric study. | BMC Cancer | 2023 | 37464378 | PubTator, text mining | PubMed |
| Second Conservative Treatment for Local Recurrence Breast Cancer: A GEC-ESTRO Oncological Outcome and Prognostic Factor Analysis. | Int J Radiat Oncol Biol Phys | 2023 | 37459998 | PubTator, text mining | PubMed |
| Immunomodulation of Skin Cancer. | Int J Mol Sci | 2023 | 37445639 | PubTator, text mining | PubMed |
| Potent molecular-targeted therapies for gastro-entero-pancreatic neuroendocrine carcinoma. | Cancer Metastasis Rev | 2023 | 37422534 | PubTator, text mining | PubMed |
| Emerging trends and research foci in autophagy of pancreatic cancer: a bibliometric and visualized study. | Front Oncol | 2023 | 37409253 | PubTator, text mining | PubMed |
| Microglia in Alzheimer's disease: pathogenesis, mechanisms, and therapeutic potentials. | Front Aging Neurosci | 2023 | 37396657 | PubTator, text mining | PubMed |
| AXL/Gas6 signaling mechanisms in the hypothalamic-pituitary-gonadal axis. | Front Endocrinol (Lausanne) | 2023 | 37396176 | PubTator, text mining | PubMed |
| Mechanisms involved in the HMGB1 modulation of tumor multidrug resistance (Review). | Int J Mol Med | 2023 | 37387415 | PubTator, text mining | PubMed |
| Prognostic survival biomarkers of tumor-fused dendritic cell vaccine therapy in patients with newly diagnosed glioblastoma. | Cancer Immunol Immunother | 2023 | 37382632 | PubTator, text mining | PubMed |
| AXL Inhibition Improves the Antitumor Activity of Chimeric Antigen Receptor T Cells. | Cancer Immunol Res | 2023 | 37378662 | PubTator, text mining | PubMed |
| Circulating Tumor DNA in the Management of Early-Stage Breast Cancer. | Cells | 2023 | 37371043 | PubTator, text mining | PubMed |
| The impact of lipid metabolism on breast cancer: a review about its role in tumorigenesis and immune escape. | Cell Commun Signal | 2023 | 37370164 | PubTator, text mining | PubMed |
| Gold nanoparticles synthesis using Gymnosporia montana L. and its biological profile: a pioneer report. | J Genet Eng Biotechnol | 2023 | 37358697 | PubTator, text mining | PubMed |
| SPI1-mediated MIR222HG transcription promotes proneural-to-mesenchymal transition of glioma stem cells and immunosuppressive polarization of macrophages. | Theranostics | 2023 | 37351164 | PubTator, text mining | PubMed |
| Inhibition of Mertk Signaling Enhances Bone Healing after Tooth Extraction. | J Dent Res | 2023 | 37350025 | PubTator, text mining | PubMed |
| Impact of anesthetist licensing examination on quality of education in Ethiopia: a qualitative study of faculty and student perceptions. | BMC Med Educ | 2023 | 37349766 | PubTator, text mining | PubMed |
| Cuproptosis-related lncRNAs are correlated with tumour metabolism and immune microenvironment and predict prognosis in pancreatic cancer patients. | IET Syst Biol | 2023 | 37341253 | PubTator, text mining | PubMed |
| The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas. | Clin Cancer Res | 2023 | 37339172 | PubTator, text mining | PubMed |
| Multi-dimensional single-cell characterization revealed suppressive immune microenvironment in AFP-positive hepatocellular carcinoma. | Cell Discov | 2023 | 37336873 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8205/papers?page=18